KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBT Margin (2016 - 2025)

Historic EBT Margin for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to 31.19%.

  • Idexx Laboratories' EBT Margin rose 5500.0% to 31.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.56%, marking a year-over-year increase of 21300.0%. This contributed to the annual value of 28.48% for FY2024, which is 5100.0% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' EBT Margin is 31.19%, which was up 5500.0% from 32.66% recorded in Q2 2025.
  • Idexx Laboratories' EBT Margin's 5-year high stood at 32.66% during Q2 2025, with a 5-year trough of 19.88% in Q2 2022.
  • Its 5-year average for EBT Margin is 28.39%, with a median of 29.26% in 2023.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -105900bps in 2022, then skyrocketed by 104200bps in 2023.
  • Quarter analysis of 5 years shows Idexx Laboratories' EBT Margin stood at 23.95% in 2021, then increased by 7bps to 25.73% in 2022, then increased by 3bps to 26.58% in 2023, then increased by 1bps to 26.87% in 2024, then grew by 16bps to 31.19% in 2025.
  • Its EBT Margin was 31.19% in Q3 2025, compared to 32.66% in Q2 2025 and 31.06% in Q1 2025.